Neuraminidase assay method originally developed by Barrett and Heath was improved for the investigation of the activity in gingival crevicular fluid, and the activities from periodontally healthy subjects and diseased patients were measured. The relationships between the activities and clinical findings, such as DI-S, CI-S, GI and pocket depth, were studied.
The following results were obtained:
1. About 85% of the activity of purified Clostridium perfringens neuraminidase (type V, Sigma Co.) was destroyed after 15-min vibration, but the addition of 5% bovine serum albumin seemed to protect the enzyme fully from denaturation during both extraction and incubation procedures.
2. The characteristics of neuraminidase activity elucidated in gingival crevicular fluid were as follows;
1) 10mM CaCl
2 activated the enzyme miximally.
2) The optimal pH was determined to be 6.0.
3) 25 mM of phosphate buffer was the best ionic strength to give a maximal enzyme activity.
4) Detergents like Triton X-100 and deoxycholic acid did not affect the enzyme activity.
3. Centrifugation, ultrafiltration, thimerosal, and chloroform inhibited the degradation of sialic acid. However, the neuraminidase activity in gingival crevicular fluid was not affected by either thimerosal or chloroform.
4. After centrifugation, the neuraminidase activity in gingival crevicular fluid increased during the stor-age at -20°C for 4 days, but the activity did not change during the storage from 4 to 12 days.
5. The mean value of neuraminidase activity in gingival crevicular fluid from periodontally diseased patients was statistically higher than that from periodontally healthy subjects. The activity showed significant correlations (p<0.01) with all the clinical findings.
View full abstract